Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening.

PubMed ID: 36326757
Public Release Type: Journal
Publication Year: 2022
Affiliation: Pediatric Endocrinology and Diabetology, Wells Center for Pediatric Research, Department of Pediatrics, and the Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.; Pediatrics Epidemiology Center, Department of Pediatrics, Morsani College of Medicine, University of South Florida, Tampa, FL.; Pediatric Endocrinology and Diabetology, Wells Center for Pediatric Research, Department of Pediatrics, and the Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.; Pediatric Endocrinology and Diabetology, Wells Center for Pediatric Research, Department of Pediatrics, and the Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.; Department of Pediatrics, University of Minnesota, Minneapolis, MN.; Departments of Pediatrics and Pathology, University of Florida College of Medicine, Gainesville, FL.; Division of Pediatric Endocrinology and Diabetes, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO.; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, University of Miami, Miami, FL.; University of Washington, Seattle, WA.; Departments of Pediatrics and Pathology, University of Florida College of Medicine, Gainesville, FL.; Pediatric Endocrinology and Diabetology, Wells Center for Pediatric Research, Department of Pediatrics, and the Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN.; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, University of Miami, Miami, FL.; Division of Diabetes and Endocrinology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.; Department of Immunobiology and Department of Internal Medicine, Yale University, New Haven, CT.; Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, University of Miami, Miami, FL.
DOI: https://doi.org/10.2337/dc22-1362
Authors: Sims Emily K, Cuthbertson David, Felton Jamie L, Ismail Heba M, Nathan Brandon M, Jacobsen Laura M, Paprocki Emily, Pugliese Alberto, Palmer Jerry, Atkinson Mark, Evans-Molina Carmella, Skyler Jay S, Redondo Maria J, Herold Kevan C, Sosenko Jay M
Request IDs: 20565 , 21294
Studies: Diabetes Prevention Trial of Type 1 Diabetes